Machine signal
Active cluster sell — 5 distinct insiders, $177.1K, window ends Aug 18, 2026.
Figures computed from official regulatory filings — .
Analysttarget 10 USD (+1092%) · consensus 5/5 · 3 buy · 0 hold · 0 sell
Ownershipinsiders 7.16% · institutions 86.88% · short 11.5% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Invivyd, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase III clinical trial for the prevention and treatment of SARS-CoV-2 virus; and VBY329, a monoclonal antibody, which is in pre-clinical trial stage for the prevention and treatment of respiratory syncytial virus and measles in neonates, infants, and children. It has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in New Haven, Connecticut.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
1 buy47 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Sheffield Ian | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Elia Marc | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lee Timothy Edward | Sell | $16.1K | SEC |
| Green Julie | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Andersen Jill | Sell | $25.9K | SEC |
| Lee Timothy Edward | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Duke William E. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Allen Robert D. III | Sell | $14.9K | SEC |
| Andersen Jill | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Duke William E. | Sell | $15.5K | SEC |
| Duke William E. | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Duke William E. | Sell | $16.1K | SEC |
| Andersen Jill | Sell | $26.9K | SEC |
| Green Julie | Sell | $16.1K | SEC |
| Allen Robert D. III | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Green Julie | Sell | $15.5K | SEC |
| Andersen Jill | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Lee Timothy Edward | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Lee Timothy Edward | Sell | $15.5K | SEC |
| Allen Robert D. III | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Green Julie | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Allen Robert D. III | Sell | $14.4K | SEC |
| Mina Michael | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MCLAUGHLIN KEVIN F | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Royan Ajay | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |